What Are Analysts Report About Gilead Sciences Inc. (GILD)

Gladys Abbott
May 20, 2017

The New York-based Jennison Associates Ltd Liability Co has invested 0% in Gilead Sciences, Inc. Apollo Management Holdings Lp acquired 356,963 shares as Radio One Inc (ROIAK)'s stock 0.00%. About 655,728 shares traded. European Equity Fund Inc (NYSE:EEA) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Css Llc increased Tesaro Inc (Call) (TSRO) stake by 448.39% reported in 2016Q4 SEC filing.

Currently Gilead Sciences Inc (NASDAQ:GILD)'s shares owned by insiders are 0.4%, whereas shares owned by institutional owners are 79.4%. (NASDAQ:GILD). Gotham Asset Mgmt Ltd Liability Corp holds 1.03M shares. The fund owned 10,197 shares of the biopharmaceutical company's stock after selling 17,984 shares during the period. About 163 shares traded.

The market cap of 86.76B for Gilead Sciences, Inc.in today's market indicated its current strength, making the company's shares a lucrative one. Landscape Capital Mgmt Limited Liability Corp accumulated 3,282 shares. 240 are owned by Exchange Capital Management Inc. Therefore 64% are positive. RBC Capital Markets maintained the shares of ATH in report on Friday, March 17 with "Outperform" rating. The firm has "Hold" rating given on Tuesday, July 26 by Needham. Sure, the percentage is encouraging but more headwinds are coming as looking out over a next 5-year period, analysts expect the company to see its earnings go down by -5.6%, annually. The rating was maintained by Citigroup with "Buy" on Friday, April 29.

For the past 5 years, Gilead Sciences, Inc.'s EPS growth has been almost 41.2%. Finally, Zacks Investment Research cut shares of Gilead Sciences from a "hold" rating to a "sell" rating in a report on Monday, February 13th. The stock has "Overweight" rating by Morgan Stanley on Friday, January 13. (NASDAQ:GILD). Fragasso Grp Incorporated has 0.37% invested in Gilead Sciences, Inc. (NASDAQ:GILD) earned "Buy" rating by Berenberg on Monday, September 12.

Investors of record on Friday, June 16th will be issued a $0.52 dividend. Its down 0.23, from 0.93 in 2016Q3. It dived, as 106 investors sold GILD shares while 656 reduced holdings. Hall Laurie J Trustee raised its stake in Gilead Sciences by 20.0% in the first quarter. 950.84 million shares or 0.69% more from 944.29 million shares in 2016Q3 were reported. Essex invested 0.42% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) latest ratings and price target changes. (NASDAQ:GILD). Fil has invested 0.29% of its portfolio in Gilead Sciences, Inc. Cowen and Company set a $100.00 target price on Gilead Sciences and gave the company a buy rating in a research report on Wednesday, January 18th. (NASDAQ:GILD) in a report released on Monday morning, StockTargetPrices.com reports.

More news: Russian, South Korean presidents hold telephone conversation

Gilead Sciences (NASDAQ:GILD) last posted its earnings results on Tuesday, May 2nd. Deutsche Savings Bank Ag invested in 7,366 shares or 0% of the stock. Selway Asset Mngmt holds 43,425 shares. Rhumbline Advisers has 31,617 shares for 0.01% of their portfolio. Wells Fargo & Mn holds 650 shares or 0% of its portfolio. Its shares have trimmed -26.01% since hitting a peak level of $88.85 on Jul. 25, 2016.

By historical standards, Gilead Sciences, Inc. remains a cheap stock. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

About Gilead Sciences Gilead Sciences, Inc is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. (NASDAQ:GILD) or 73,333 shares. The stock has earnings growth of -51.10% yoy and showed a low EPS growth of -9.20% over the past five years. MARTIN JOHN C also sold $7.33 million worth of Gilead Sciences, Inc. GILD's ROA is 23.93%, while industry's average is -1.22%. Hudson Valley Inv Advsr Adv invested 0.19% in Gilead Sciences, Inc. Alton Gregg H sold $341,529 worth of stock. Powershares Financial Preferre (PGF) was reduced too. A rating of 3 would signify a consensus Hold recommendation. The stock has "Buy" rating by Citigroup on Wednesday, September 7. Bank of America upgraded it to "Neutral" rating and $107 target in Monday, January 18 report. Fayerweather Charles has 0.75% invested in Gilead Sciences, Inc. The monthly performance exhibited a rate of -1.47% with an annual performance rate of -19.35%. (NASDAQ:GILD) on Monday, September 21 with "Buy" rating. Oppenheimer has "Outperform" rating and $120 target. The firm has "Buy" rating by Argus Research given on Thursday, November 19. As per Tuesday, August 11, the company rating was upgraded by MoffettNathanson.

Investors sentiment increased to 1.24 in 2016 Q4. Its down 0.23, from 0.93 in 2016Q3. 115 funds opened positions while 683 raised stakes. (NASDAQ:AKRX) plummeted -0.12% to $33.10. Moreover, Wealthtrust has 0.01% invested in Verizon Communications Inc. Putnam Investments Llc has 0.13% invested in General Dynamics Corporation (NYSE:GD) for 314,438 shares. 60,296 are held by Fifth Third Bancorporation. Thematic Prtn Limited Com owns 2.11% invested in Gilead Sciences, Inc. Carl Domino accumulated 5,375 shares. Gilead Sciences, Inc. NASDAQ has an Earning Per Share for the upcoming year at -16.50%. Blue Bell Private Wealth Lc reported 34,279 shares or 0.16% of all its holdings. California Employees Retirement System has invested 0.22% in General Dynamics Corporation (NYSE:GD). (NYSE:VZ) or 258,776 shares.

Since December 1, 2016, it had 0 insider buys, and 10 insider sales for $35.91 million activity. WILSON GAYLE E had sold 20,365 shares worth $1.41M on Thursday, February 23. A rating of 4 or 5 would indicate a consensus Sell. Lindell Jody S sold $966,916 worth of stock or 5,000 shares.

Other reports by LeisureTravelAid

Discuss This Article